pentostatin has been researched along with Kidney-Neoplasms* in 3 studies
1 trial(s) available for pentostatin and Kidney-Neoplasms
Article | Year |
---|---|
Phase II study of 2'-deoxycoformycin in patients with renal cell carcinoma. A National Cancer Institute of Canada Clinical Trials Group study.
The National Cancer Institute of Canada Clinical Trials Group undertook a phase II study of 2'-deoxycoformycin in patients with metastatic renal cell carcinoma. When 2'-deoxycoformycin 4 mg/m2 was administered intravenously weekly for three weeks then every two weeks no significant antitumor activity was noted in 19 evaluable patients. Toxic effects experienced were as expected, consisting primarily of nausea/vomiting, anorexia, and lethargy. It is concluded that 2'-deoxycoformycin at this dose and schedule has no clinical activity in the treatment of metastatic renal cell carcinoma. Topics: Adult; Aged; Carcinoma, Renal Cell; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Pentostatin | 1991 |
2 other study(ies) available for pentostatin and Kidney-Neoplasms
Article | Year |
---|---|
Pentostatin effective as preparative regimen for kidney transplants.
Topics: Humans; Immunosuppressive Agents; Immunotherapy, Adoptive; Kidney Neoplasms; Kidney Transplantation; Pentostatin; Transplantation, Homologous | 2001 |
Evaluation of deoxycoformycin in patients with advanced renal cell carcinoma. An ECOG pilot study.
Topics: Adult; Aged; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Pentostatin; Pilot Projects | 1992 |